88 related articles for article (PubMed ID: 27994763)
1. Discovery of 2'-α-C-Methyl-2'-β-C-fluorouridine Phosphoramidate Prodrugs as Inhibitors of Hepatitis C Virus.
Zeng D; Zhang R; Nie Q; Cao L; Shang L; Yin Z
ACS Med Chem Lett; 2016 Dec; 7(12):1197-1201. PubMed ID: 27994763
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of 6-substituted-5-fluorouridine ProTides.
Slusarczyk M; Ferla S; Brancale A; McGuigan C
Bioorg Med Chem; 2018 Feb; 26(3):551-565. PubMed ID: 29277307
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of a novel β-D-2'-deoxy-2'-α-fluoro-2'-β-C-(fluoromethyl)uridine phosphoramidate prodrug for the treatment of hepatitis C virus infection.
Li E; Wang Y; Yu W; Lv Z; Peng Y; Liu B; Li S; Ho W; Wang Q; Li H; Chang J
Eur J Med Chem; 2018 Jan; 143():107-113. PubMed ID: 29172078
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anti-HCV activity of a series of β-d-2'-deoxy-2'-dibromo nucleosides and their corresponding phosphoramidate prodrugs.
Chen Z; Cox BD; Garnier-Amblard EC; McBrayer TR; Coats SJ; Schinazi RF; Amblard F
Bioorg Med Chem Lett; 2017 Dec; 27(23):5296-5299. PubMed ID: 29066308
[TBL] [Abstract][Full Text] [Related]
5. Aspartic acid based nucleoside phosphoramidate prodrugs as potent inhibitors of hepatitis C virus replication.
Maiti M; Maiti M; Rozenski J; De Jonghe S; Herdewijn P
Org Biomol Chem; 2015 May; 13(18):5158-74. PubMed ID: 25849139
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Anti-HCV Activity of a Novel 2',3'-Dideoxy-2'-α-fluoro-2'-β-
Yu W; Li E; Lv Z; Liu K; Guo X; Liu Y; Chang J
ACS Med Chem Lett; 2017 Jun; 8(6):682-684. PubMed ID: 28626533
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anti-HCV activity of β-d-2'-deoxy-2'-α-chloro-2'-β-fluoro and β-d-2'-deoxy-2'-α-bromo-2'-β-fluoro nucleosides and their phosphoramidate prodrugs.
Ovadia R; Khalil A; Li H; De Schutter C; Mengshetti S; Zhou S; Bassit L; Coats SJ; Amblard F; Schinazi RF
Bioorg Med Chem; 2019 Feb; 27(4):664-676. PubMed ID: 30655167
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship of uridine-based nucleoside phosphoramidate prodrugs for inhibition of dengue virus RNA-dependent RNA polymerase.
Wang G; Lim SP; Chen YL; Hunziker J; Rao R; Gu F; Seh CC; Ghafar NA; Xu H; Chan K; Lin X; Saunders OL; Fenaux M; Zhong W; Shi PY; Yokokawa F
Bioorg Med Chem Lett; 2018 Jul; 28(13):2324-2327. PubMed ID: 29801997
[TBL] [Abstract][Full Text] [Related]
9. The phosphoramidate ProTide approach greatly enhances the activity of beta-2'-C-methylguanosine against hepatitis C virus.
McGuigan C; Perrone P; Madela K; Neyts J
Bioorg Med Chem Lett; 2009 Aug; 19(15):4316-20. PubMed ID: 19523820
[TBL] [Abstract][Full Text] [Related]
10. Preclinical evaluation of AT-527, a novel guanosine nucleotide prodrug with potent, pan-genotypic activity against hepatitis C virus.
Good SS; Moussa A; Zhou XJ; Pietropaolo K; Sommadossi JP
PLoS One; 2020; 15(1):e0227104. PubMed ID: 31914458
[TBL] [Abstract][Full Text] [Related]
11. β-D-2'-α-F-2'-β-C-Methyl-6-O-substituted 3',5'-cyclic phosphate nucleotide prodrugs as inhibitors of hepatitis C virus replication: a structure-activity relationship study.
Du J; Bao D; Chun BK; Jiang Y; Reddy PG; Zhang HR; Ross BS; Bansal S; Bao H; Espiritu C; Lam AM; Murakami E; Niu C; Micolochick Steuer HM; Furman PA; Otto MJ; Sofia MJ
Bioorg Med Chem Lett; 2012 Sep; 22(18):5924-9. PubMed ID: 22892115
[TBL] [Abstract][Full Text] [Related]
12. Prodrugs of imidazotriazine and pyrrolotriazine C-nucleosides can increase anti-HCV activity and enhance nucleotide triphosphate concentrations in vitro.
Tyndall EM; Draffan AG; Frey B; Pool B; Halim R; Jahangiri S; Bond S; Wirth V; Luttick A; Tilmanis D; Thomas J; Porter K; Tucker SP
Bioorg Med Chem Lett; 2015 Feb; 25(4):869-73. PubMed ID: 25592710
[TBL] [Abstract][Full Text] [Related]
13. Phosphoramidate prodrugs of 2'-C-methylcytidine for therapy of hepatitis C virus infection.
Gardelli C; Attenni B; Donghi M; Meppen M; Pacini B; Harper S; Di Marco A; Fiore F; Giuliano C; Pucci V; Laufer R; Gennari N; Marcucci I; Leone JF; Olsen DB; MacCoss M; Rowley M; Narjes F
J Med Chem; 2009 Sep; 52(17):5394-407. PubMed ID: 19725579
[TBL] [Abstract][Full Text] [Related]
14. Cyclic monophosphate prodrugs of base-modified 2'-C-methyl ribonucleosides as potent inhibitors of hepatitis C virus RNA replication.
Gunic E; Girardet JL; Ramasamy K; Stoisavljevic-Petkov V; Chow S; Yeh LT; Hamatake RK; Raney A; Hong Z
Bioorg Med Chem Lett; 2007 May; 17(9):2452-5. PubMed ID: 17331721
[TBL] [Abstract][Full Text] [Related]
15. NMR-based conformational analysis of 2',6-disubstituted uridines and antiviral evaluation of new phosphoramidate prodrugs.
da Paixão Soares F; Groaz E; Lescrinier E; Neyts J; Leyssen P; Herdewijn P
Bioorg Med Chem; 2015 Sep; 23(17):5809-15. PubMed ID: 26210159
[TBL] [Abstract][Full Text] [Related]
16. Bifunctional aryloxyphosphoramidate prodrugs of 2'-C-Me-uridine: synthesis and anti-HCV activity.
Maiti M; Gao LJ; Huang C; Ptak RG; Murray MG; De Jonghe S; Herdewijn P
Org Biomol Chem; 2016 Sep; 14(37):8743-8757. PubMed ID: 27714209
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and antiviral evaluation of 2'-C-methyl branched guanosine pronucleotides: the discovery of IDX184, a potent liver-targeted HCV polymerase inhibitor.
Sizun G; Pierra C; Peyronnet J; Badaroux E; Rabeson C; Benzaria-Prad S; Surleraux D; Loi AG; Musiu C; Liuzzi M; Seifer M; Standring D; Sommadossi JP; Gosselin G
Future Med Chem; 2015; 7(13):1675-700. PubMed ID: 26424162
[TBL] [Abstract][Full Text] [Related]
18. Discovery of pyrimidine nucleoside dual prodrugs and pyrazine nucleosides as novel anti-HCV agents.
Guo S; Xu M; Guo Q; Zhu F; Jiang X; Xie Y; Shen J
Bioorg Med Chem; 2019 Mar; 27(5):748-759. PubMed ID: 30683552
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Evaluation of 2,6-Modified Purine 2'-C-Methyl Ribonucleosides as Inhibitors of HCV Replication.
Zhou L; Zhang H; Tao S; Ehteshami M; Cho JH; McBrayer TR; Tharnish P; Whitaker T; Amblard F; Coats SJ; Schinazi RF
ACS Med Chem Lett; 2016 Jan; 7(1):17-22. PubMed ID: 26819659
[TBL] [Abstract][Full Text] [Related]
20. Phosphoramidate prodrugs of (-)-β-D-(2R,4R)-dioxolane-thymine (DOT) as potent anti-HIV agents.
Wang P; Rachakonda S; Zennou V; Keilman M; Niu C; Bao D; Ross BS; Furman PA; Otto MJ; Sofia MJ
Antivir Chem Chemother; 2012 May; 22(5):217-38. PubMed ID: 22358223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
